aspirin has been researched along with nicorandil in 15 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (6.67) | 18.7374 |
| 1990's | 4 (26.67) | 18.2507 |
| 2000's | 4 (26.67) | 29.6817 |
| 2010's | 3 (20.00) | 24.3611 |
| 2020's | 3 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Baert, B; Beetens, J; Bodé, S; De Spiegeleer, B; Deconinck, E; Lambert, J; Slegers, G; Slodicka, M; Stoppie, P; Van Gele, M; Vander Heyden, Y | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Hosoda, S; Uchida, T | 1 |
| Nakamura, Y; Sakai, K; Sugimoto, T; Yamazaki, T | 1 |
| Bueno, O; Zavecz, JH | 1 |
| Shetty, K | 1 |
| Akima, M; Katsuyama, I; Sakai, K | 1 |
| Ahn, YK; Bae, Y; Cho, JG; Cho, JH; Jeong, MH; Kang, JC; Kang, KT; Kim, KH; Kim, NH; Kim, SH; Lee, SH; Park, JC; Rhew, JY | 1 |
| Goswami, SG; Patel, HM; Santani, DD | 1 |
| Kurihara, H; Matsumoto, S; Matsuyama, T; Nakagawa, T; Nakata, A; Tamura, R; Yachiku, K; Yoshino, T | 1 |
| Battler, A; Dvir, D | 1 |
| Huang, Q; Pei, A; Sui, XQ; Wang, SS; Wang, WT | 1 |
| Bhandari, S; Dadhwal, DS; Dogra, V; Gupta, S; Raina, S; Sharma, A; Sharma, C; Singh, B; Sood, V | 1 |
| Hirata, A; Hosomi, K; Jouta, M; Kawasaki, N; Nakamura, T; Ogata, F; Ozaki, Y; Tanei, S; Yamashiro, K; Yokoyama, S | 1 |
3 review(s) available for aspirin and nicorandil
| Article | Year |
|---|---|
Pharmacologic therapy of angina pectoris.
Topics: Acetanilides; Adrenergic beta-Antagonists; Angina Pectoris; Aspirin; Calcium Channel Blockers; Drug Therapy, Combination; Enoximone; Heparin; Humans; Isosorbide Dinitrate; Niacinamide; Nicorandil; Nitroglycerin; Piperazines; Ranolazine; Vasodilator Agents | 1995 |
Prescribing for angina.
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Aspirin; Calcium Channel Blockers; Humans; Myocardial Ischemia; Niacinamide; Nicorandil; Nitrates; Vasodilator Agents | 1994 |
Conventional and novel drug therapeutics to relief myocardial ischemia.
Topics: Acetanilides; Adrenergic beta-Antagonists; Angina Pectoris; Angiotensin-Converting Enzyme Inhibitors; Aspirin; Benzazepines; Calcium Channel Blockers; Cardiovascular Agents; Cardiovascular System; Coronary Artery Disease; Hemodynamics; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Ivabradine; Nicorandil; Nitrates; Piperazines; Ranolazine | 2010 |
3 trial(s) available for aspirin and nicorandil
| Article | Year |
|---|---|
Clinical outcome of percutaneous coronary intervention with antecedent mutant t-PA administration for acute myocardial infarction.
Topics: Aged; Angioplasty, Balloon, Coronary; Aspirin; Combined Modality Therapy; Coronary Angiography; Coronary Restenosis; Female; Humans; Male; Middle Aged; Myocardial Infarction; Nicorandil; Plasminogen Activators; Platelet Aggregation Inhibitors; Stents; Vasodilator Agents | 2004 |
Cardiovascular magnetic resonance image analysis and mechanism study for the changes after treatments for primary microvascular angina pectoris.
Topics: Adolescent; Adult; Aged; Aspirin; Cardiovascular System; Coronary Angiography; Diltiazem; Drug Therapy, Combination; Electrocardiography; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Magnetic Resonance Imaging; Male; Microvascular Angina; Middle Aged; Nicorandil; Nitroglycerin; Randomized Controlled Trials as Topic; Treatment Outcome; Vasodilator Agents; Young Adult | 2021 |
A randomized open-label trial to evaluate the efficacy and safety of triple therapy with aspirin, atorvastatin, and nicorandil in hospitalised patients with SARS Cov-2 infection: A structured summary of a study protocol for a randomized controlled trial.
Topics: Aspirin; Atorvastatin; COVID-19; Humans; India; Nicorandil; Prospective Studies; Randomized Controlled Trials as Topic; SARS-CoV-2; Treatment Outcome | 2021 |
9 other study(ies) available for aspirin and nicorandil
| Article | Year |
|---|---|
Transdermal penetration behaviour of drugs: CART-clustering, QSPR and selection of model compounds.
Topics: Anti-Inflammatory Agents; Cell Membrane Permeability; Cluster Analysis; Drug Evaluation, Preclinical; Humans; Models, Biological; Predictive Value of Tests; Quantitative Structure-Activity Relationship; Regression Analysis; Skin; Skin Absorption | 2007 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
[Drug therapy of unstable angina].
Topics: Adrenergic beta-Antagonists; Angina, Unstable; Aspirin; Calcium Channel Blockers; Drug Therapy, Combination; Heparin; Humans; Niacinamide; Nicorandil; Nitroglycerin | 1990 |
Protective effects of the antianginal agent nicorandil on arachidonate-induced sudden death in rats: comparison with several antianginal agents and cyclooxygenase inhibitors.
Topics: Angina Pectoris; Animals; Arachidonic Acid; Arachidonic Acids; Aspirin; Cyclooxygenase Inhibitors; Death, Sudden; Diltiazem; Indomethacin; Male; Mice; Niacinamide; Nicorandil; Nitroglycerin; Rats; Rats, Inbred Strains; Vasodilator Agents | 1985 |
Effects of nicorandil on experimentally induced gastric ulcers in rats: a possible role of K(ATP) channels.
Topics: Adenosine Triphosphate; Animals; Anti-Ulcer Agents; Aspirin; Cimetidine; Gastric Acid; Gastric Mucosa; Glyburide; Hypoglycemic Agents; Immersion; Male; Nicorandil; Potassium Channels; Rats; Rats, Sprague-Dawley; Regional Blood Flow; Restraint, Physical; Stomach; Stomach Ulcer; Vasodilator Agents; Water | 1999 |
Successful management of intractable coronary spasm with a coronary stent.
Topics: Adult; Amlodipine; Aspirin; Calcium Channel Blockers; Cardiovascular Agents; Coronary Angiography; Coronary Artery Disease; Coronary Vasospasm; Diltiazem; Doxazosin; Drug Resistance; Drug Therapy, Combination; Ergonovine; Humans; Isosorbide Dinitrate; Male; Myocardial Infarction; Nicorandil; Nitrates; Pyridines; Stents; Ticlopidine; Ventricular Fibrillation | 2000 |
Evaluation of the effects of nicorandil on experimentally induced gastric ulcers.
Topics: Animals; Anti-Ulcer Agents; Aspirin; Cimetidine; Disease Models, Animal; Dose-Response Relationship, Drug; Ethanol; Female; Gastric Mucosa; Glyburide; Ligation; Male; Nicorandil; Proteins; Pylorus; Rats; Rats, Wistar; Stomach; Stomach Ulcer | 2001 |
Adverse event profiles of microscopic colitis in the Japanese Adverse Drug Event Report (JADER) database.
Topics: Adverse Drug Reaction Reporting Systems; Aspirin; Colitis, Microscopic; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Japan; Lansoprazole; Middle Aged; Nicorandil; United States | 2022 |